Baker Bros. Advisors LP Edgewise Therapeutics, Inc. Transaction History
Baker Bros. Advisors LP
- $9.02 Billion
- Q4 2024
A detailed history of Baker Bros. Advisors LP transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Baker Bros. Advisors LP holds 6,155,940 shares of EWTX stock, worth $154 Million. This represents 1.82% of its overall portfolio holdings.
Number of Shares
6,155,940
Previous 5,840,059
5.41%
Holding current value
$154 Million
Previous $156 Million
5.45%
% of portfolio
1.82%
Previous 1.67%
Shares
5 transactions
Others Institutions Holding EWTX
# of Institutions
215Shares Held
98.3MCall Options Held
885KPut Options Held
232K-
Orbimed Advisors LLC San Diego, CA15MShares$376 Million10.86% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$223 Million3.85% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$150 Million0.0% of portfolio
-
Novo Holdings Hellerup, G75MShares$125 Million10.85% of portfolio
-
Janus Henderson Group PLC London, X04.98MShares$125 Million0.07% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $1.58B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...